Legal Psilocybin for Terminal Cancer Patients: Compassionate Access & End-of-Life Care
A podcast examining the growing movement to make psilocybin legally available to terminally ill patients — covering the history of end-of-life psilocybin research from Griffiths' 2006 mystical experience study through current compassionate access programs, and what clinical evidence supports its use in existential distress at end of life.
Source Research Papers
Citations in APA 7 format. All studies were sourced from peer-reviewed journals via Google Scholar. Unfamiliar terms? See the plain-language glossary →
de la Salle, S., Kettner, H., Thibault Lévesque, J., Garel, N., Dames, S., Patchett-Marble, R., Rej, S., Gloeckler, S., Erritzoe, D., Carhart-Harris, R., & Greenway, K. T. (2024). Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy. Scientific Reports, 14, 15353. https://doi.org/10.1038/s41598-024-66817-0
26 Canadians who received psilocybin therapy through a special-access program reported real, lasting improvements in their mental health. It wasn't a controlled trial, but it's a valuable look at how the treatment works outside the lab.
Shop Related Spores
Laboratory-grade Psilocybe cubensis spore syringes for microscopy research.